Fighting for Hemp-Derived CBD in California

Recently, the California Department of Health issued this public statement about hemp-derived cannabidiol (CBD).  In summary, the agency argues that hemp-derived CBD products CANNOT be sold in retail markets in the Golden State. The US Hemp Roundtable refuses to accept this conclusion. Today, we have sent the agency this letter, strongly arguing that the Department’s interpretation…

Read More

Hemp Progress in the Lone Star State

While forty states have passed some form of legislation legalizing hemp, the nation’s second largest state, Texas, hasn’t yet joined the party.  Yesterday, however, proved to be a Texas-sized boot step in the right direction. Testifying before the Texas House Agriculture & Livestock Committee, US Hemp Roundtable Board member Jeff Williams and our General Counsel…

Read More

California, Here We Come

Last week, the California Department of Health issued this public statement about hemp-derived cannabidiol (CBD).  In summary, they argue that hemp-derived CBD products CANNOT be sold in retail markets in the Golden State. The US Hemp Roundtable strongly disagrees with the agency’s legal conclusions.  We will not let this stand without a fight. In the coming…

Read More

What’s next for The Hemp Farming Act?

As you undoubtedly know by now, history was made last week when the U.S. Senate overwhelmingly passed its version of the 2018 Farm Bill, which included, in whole, the Hemp Farming Act of 2018. If fully enacted, hemp and popular products like hemp-derived CBD would be permanently legalized, treated as agricultural commodities, and removed from the…

Read More

Senate Farm Bill Passes WITH Hemp Farming Act!

Great news!  The Senate Farm Bill just passed – and it includes ALL of the Hemp Farming Act language, including the permanent legalization of hemp and products such as hemp-derived CBD. This is HUGE.  But the battle has not yet been won. And we need your help. A House/Senate conference committee will soon meet to…

Read More

FDA Approval of Epidiolex: No Legal Impact on Hemp-Derived CBD

Yesterday, as long anticipated, the Food and Drug Administration (FDA) approved GW Pharmaceutical’s Epidiolex, a cannabidiol (CBD) oral solution for the treatment of seizures associated with two forms of epilepsy.  Please see the FDA’s press release here, and this statement from the FDA’s Commissioner. The US Hemp Roundtable has reviewed the release with its FDA…

Read More

Movement in Michigan

On May 11, Michigan’s Department of Licensing and Regulatory Affairs (LARA) issued an advisory bulletin on hemp and cannabidiol (“CBD”) that raised concerns in the industry.  Specifically, the implication of the guidance was that CBD would be regulated under the same strict requirements for medical marijuana. Hemp is not marijuana, and hemp-derived CBD is not…

Read More

23,453 emails!

Last week, after learning that Senator Chuck Grassley filed an amendment to the Farm Bill which might have restricted the sale of hemp-derived products such as CBD, we asked you to take action.   You responded.  Wow, did you respond!  By the next morning, you broke the Internet – more than 100,000 social media interactions,…

Read More